DexCom, Inc. (DXCM)
$84.11-0.36%Close
SELLBEAR · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV16.9%–98.7%
- Market cap
- $32.5B
- Beta
- 1.48
- P/E (TTM)
- 32.20
- IV-%ile
- 49
- IV ATM
- 41.6%
- Short % float
- 3.65%
- Days to cover
- 3.2
- SI change
- -18.8%
- 1W
- -1.46%
- 1M
- -0.47%
- vs SPY 1W
- -2.62%
- vs SPY 1M
- -3.47%
Industry peers
FMP comparable companies · ranked by market cap
- 603087.SSGan & Lee Pharmaceuticals.$46.3B$77.40
- PODDSELLInsulet Corp.$9.3BRECOVERYQ 16$134.36+0.60%
- YPHDFYpsomed Holding AG$5.7B$436.55
- MMEDSELLMiniMed Group, Inc.$5.4BQ 22$19.11-0.45%
- TNDMSELLTandem Diabetes Care, Inc.$1.1BCRISISQ -8$15.84+2.74%
- BBNXSELLBeta Bionics, Inc.$813MCRISISQ -6$18.08+1.15%
- MMEDVMiniMed Group, Inc.$540M$19.30
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 58
- VALUE
- 27
- GROWTH
- 56
- GARP
- 56
- TYPE
- Growth Compounder (blended)
Composite of Value · Growth · GARP
ROIC21.7%
REV YoY-
ROE36.2%
EPS YoY-
ROA15.5%
GROSS62
OP23
NET20
[VALUATION]
P/E TTM32.20
P/E FWD30.29
SECTOR PE20.47
INDUSTRY PE22.50
P/B12.21
P/FCF-
EV/EBITDA20.37
EV/EBIT-
PEG1.80
FCF YIELD-
RISK
INT COV-
D/E53.35
ALTMAN Z-
CURR RATIO1.73
ND/EBITDA-
BETA1.48
